Finance

Lists
ETON:NASDAQ
Eton Pharmaceuticals Inc
$54.88
0.00%
(0.00) 1D
Oct 7, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ETON...
Mkt. cap
1.57B
Avg. vol.
579.29K
Volume
4.62K
P/E ratio
142.27
52-wk high
$66.37
52-wk low
$14.27
EPS
$0.39
Beta
0.90
Shares outstanding
28.58M
No. of employees
44
Mkt. cap
1.57B
Avg. vol.
579.29K
Volume
4.62K
P/E ratio
142.27
52-wk high
$66.37
52-wk low
$14.27
EPS
$0.39
Beta
0.90
Shares outstanding
28.58M
No. of employees
44
News stories
From web sources and news partners
About Eton Pharmaceuticals Inc
CEO-
Employees44
Founded2017
Headquarters-
SectorPharmaceutical industry
Websiteetonpharma.com
Analyst ratings
Based on 3 analysts giving stock ratings to ETON in the past 3 months
Strong buy
Buy
3
Hold
0
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for ETON in the last 3 months.
Highest
Current $54.88
$76.00 (+38.48%)
Average
$68.67 (+25.13%)
Lowest
$60.00 (+9.33%)
Analyst
Recommendation
Action
Price target
Projected
Date
Swayampakula Ramakanth
H.C. Wainwright
Buy
Reiterated
$70.00
+27.6%
10/01/2026
Chase Knickerbocker
Craig-Hallum
Buy
Reiterated
$76.00
+38.5%
08/14/2026
Gary Nachman
Canaccord Genuity
Buy
Reiterated
$60.00
+9.3%
07/30/2026
Madison Elsaadi
B. Riley Securities
Buy
Reiterated
$40.00
-27.1%
06/25/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
22.46M
21.28M
24.27M
37.59M
Cost of goods sold
13.28M
6.76M
9.18M
11.53M
Cost of revenue
13.28M
6.76M
9.18M
11.53M
Research and development expenses
1.11M
1.78M
1.88M
993.00K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
8.11M
8.28M
10.45M
11.63M
Operating expense
9.22M
10.06M
12.32M
12.62M
Total operating expenses
22.50M
16.82M
21.50M
24.14M
Operating income
-39.00K
4.47M
2.76M
13.44M
Other non operating income
-
-
-
-
EBT including unusual items
-1.96M
1.41M
1.57M
11.72M
EBT excluding unusual items
-631.00K
3.42M
1.92M
12.37M
Income tax expense
-28.00K
-69.00K
20.00K
140.00K
Effective tax rate
1.43%
-4.88%
1.27%
1.19%
Other operating expenses
-
-
-
-
Net income
-1.93M
1.48M
1.55M
11.58M
Net profit margin
-8.58%
6.97%
6.40%
30.80%
Earnings per share
0.04
0.19
0.14
0.43
Interest and investment income
620.00K
158.00K
296.00K
-
Interest expense
-1.21M
-1.21M
-1.14M
-1.08M
Net interest expenses
-592.00K
-1.05M
-840.00K
-1.08M
Depreciation and amortization charges
-
-
-
-
EBITDA
970.00K
5.48M
3.90M
14.83M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps